519 related articles for article (PubMed ID: 25352419)
1. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.
Zhao Y; Gong CX
Cell Mol Neurobiol; 2015 Jan; 35(1):101-10. PubMed ID: 25352419
[TBL] [Abstract][Full Text] [Related]
2. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?
Du SQ; Wang XR; Xiao LY; Tu JF; Zhu W; He T; Liu CZ
Mol Neurobiol; 2017 Jul; 54(5):3670-3682. PubMed ID: 27206432
[TBL] [Abstract][Full Text] [Related]
4. Remote Ischemic Conditioning: A Potential Treatment for Chronic Cerebral Hypoperfusion.
Ma X; Ji C
Eur Neurol; 2022; 85(4):253-259. PubMed ID: 35104816
[TBL] [Abstract][Full Text] [Related]
5. Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.
Di Marco LY; Venneri A; Farkas E; Evans PC; Marzo A; Frangi AF
Neurobiol Dis; 2015 Oct; 82():593-606. PubMed ID: 26311408
[TBL] [Abstract][Full Text] [Related]
6. Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
J Alzheimers Dis; 2016 Mar; 52(1):113-26. PubMed ID: 27060955
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model.
Feng T; Yamashita T; Shang J; Shi X; Nakano Y; Morihara R; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Ohta Y; Abe K
J Alzheimers Dis; 2019; 71(1):327-339. PubMed ID: 31403949
[TBL] [Abstract][Full Text] [Related]
8. Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model.
Choi BR; Lee SR; Han JS; Woo SK; Kim KM; Choi DH; Kwon KJ; Han SH; Shin CY; Lee J; Chung CS; Lee SR; Kim HY
Stroke; 2011 Sep; 42(9):2595-604. PubMed ID: 21737797
[TBL] [Abstract][Full Text] [Related]
9. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?
de la Torre JC
Ann N Y Acad Sci; 2000 Apr; 903():424-36. PubMed ID: 10818533
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer's disease model mouse.
Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Li X; Tian F; Liu X; Huang Y; Shi X; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Neurosci Res; 2019 Jun; 143():61-70. PubMed ID: 29885344
[TBL] [Abstract][Full Text] [Related]
11. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress.
Liu H; Zhang J
Int J Neurosci; 2012 Sep; 122(9):494-9. PubMed ID: 22519891
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
Feng T; Hu X; Fukui Y; Bian Z; Bian Y; Sun H; Takemoto M; Yunoki T; Nakano Y; Morihara R; Abe K; Yamashita T
J Alzheimers Dis; 2022; 86(4):1973-1982. PubMed ID: 35253748
[TBL] [Abstract][Full Text] [Related]
13. Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice.
Zhao Y; Gu JH; Dai CL; Liu Q; Iqbal K; Liu F; Gong CX
Front Aging Neurosci; 2014; 6():10. PubMed ID: 24575038
[TBL] [Abstract][Full Text] [Related]
14. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.
Iadecola C
Acta Neuropathol; 2010 Sep; 120(3):287-96. PubMed ID: 20623294
[TBL] [Abstract][Full Text] [Related]
15. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
16. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
Boese AC; Hamblin MH; Lee JP
Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
[TBL] [Abstract][Full Text] [Related]
17. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
18. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.
de la Torre JC
Lancet Neurol; 2004 Mar; 3(3):184-90. PubMed ID: 14980533
[TBL] [Abstract][Full Text] [Related]
19. Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
Lee JI; Lim JS; Hong JH; Kim S; Lee SW; Ji HD; Won KS; Song BI; Kim HW
PLoS One; 2022; 17(2):e0262224. PubMed ID: 35143502
[TBL] [Abstract][Full Text] [Related]
20. Chronic Cerebral Hypoperfusion Induced Synaptic Proteome Changes in the rat Cerebral Cortex.
Völgyi K; Gulyássy P; Todorov MI; Puska G; Badics K; Hlatky D; Kékesi KA; Nyitrai G; Czurkó A; Drahos L; Dobolyi A
Mol Neurobiol; 2018 May; 55(5):4253-4266. PubMed ID: 28620701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
